Roussy–Lévy syndrome

From WikiMD's WELLNESSPEDIA


Roussy–Lévy syndrome
Synonyms Hereditary areflexic dystasia
Pronounce N/A
Specialty N/A
Symptoms Areflexia, gait ataxia, tremor, muscle weakness
Complications N/A
Onset Childhood
Duration Lifelong
Types N/A
Causes Genetic mutation in PMP22
Risks Family history
Diagnosis Genetic testing, nerve conduction study
Differential diagnosis Charcot–Marie–Tooth disease, Friedreich's ataxia
Prevention N/A
Treatment Physical therapy, orthopedic devices
Medication N/A
Prognosis Variable, generally slowly progressive
Frequency Rare
Deaths N/A


Roussy–Lévy syndrome is a rare, inherited neurological disorder characterized by a combination of muscle weakness, loss of sensation in the extremities, and a lack of coordination. It is a form of Charcot-Marie-Tooth disease, a group of disorders that affect the peripheral nerves.

Symptoms[edit]

The symptoms of Roussy–Lévy syndrome typically begin in childhood and progress slowly over time. They include:

Causes[edit]

Roussy–Lévy syndrome is caused by mutations in the MPZ or PMP22 genes. These genes are involved in the production of proteins that are essential for the normal function of peripheral nerves. The mutations lead to a disruption in the way these nerves transmit signals, resulting in the symptoms of the disorder.

Diagnosis[edit]

The diagnosis of Roussy–Lévy syndrome is based on a combination of clinical symptoms, family history, and genetic testing. Electromyography and nerve conduction studies may also be used to confirm the diagnosis.

Treatment[edit]

There is currently no cure for Roussy–Lévy syndrome. Treatment is focused on managing symptoms and improving quality of life. This may include physical therapy, occupational therapy, and the use of assistive devices such as braces or wheelchairs. Medications may also be used to manage symptoms such as tremors.

Prognosis[edit]

The prognosis for individuals with Roussy–Lévy syndrome varies. The disorder is progressive, meaning symptoms will worsen over time. However, the rate of progression can vary widely from person to person.

See also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.